Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Endocrine Sensitive HER2+/HR+ Breast Cancer
Interventions: DRUG: Pertuzumab
Sponsor: Istituto Oncologico Veneto IRCCS
Collaborators: Association for Translational Research in Oncology (AS.T.R.O.)